BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16394514)

  • 1. Inhibitory effects of amlodipine and fluvastatin on the deposition of advanced glycation end products in aortic wall of cholesterol and fructose-fed rabbits.
    Akira K; Amano M; Okajima F; Hashimoto T; Oikawa S
    Biol Pharm Bull; 2006 Jan; 29(1):75-81. PubMed ID: 16394514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.
    Mitani H; Egashira K; Kimura M
    Pharmacol Res; 2003 Nov; 48(5):417-27. PubMed ID: 12967585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits.
    Rikitake Y; Kawashima S; Takeshita S; Yamashita T; Azumi H; Yasuhara M; Nishi H; Inoue N; Yokoyama M
    Atherosclerosis; 2001 Jan; 154(1):87-96. PubMed ID: 11137086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvastatin suppresses atherosclerotic progression, mediated through its inhibitory effect on endothelial dysfunction, lipid peroxidation, and macrophage deposition.
    Bandoh T; Mitani H; Niihashi M; Kusumi Y; Kimura M; Ishikawa J; Totsuka T; Sakurai I; Hayashi S
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):136-44. PubMed ID: 10630744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits.
    Mitani H; Bandoh T; Ishikawa J; Kimura M; Totsuka T; Hayashi S
    Br J Pharmacol; 1996 Nov; 119(6):1269-75. PubMed ID: 8937733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the calcium channel blocker amlodipine on serum and aortic cholesterol, lipid peroxidation, antioxidant status and aortic histology in cholesterol-fed rabbits.
    Turgan N; Habif S; Kabaroğlu CG; Mutaf I; Ozmen D; Bayindir O; Uysal A
    J Biomed Sci; 2003; 10(1):65-72. PubMed ID: 12566988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits.
    Mitani H; Egashira K; Ohashi N; Yoshikawa M; Niwa S; Nonomura K; Nakashima A; Kimura M
    Pharmacology; 2003 Jul; 68(3):121-30. PubMed ID: 12784083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
    Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early intervention on atherosclerosis by fluvastatin and lectin-like oxidized low-density lipoprotein receptor-1 expression in atherosclerotic arteries in immature rabbits].
    Yu YH; Wang Y; Chen Y; Liu ZZ; Sun SZ; Meng XH
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):762-6. PubMed ID: 16255856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine.
    Chen L; Haught WH; Yang B; Saldeen TG; Parathasarathy S; Mehta JL
    J Am Coll Cardiol; 1997 Aug; 30(2):569-75. PubMed ID: 9247534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
    Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
    Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress.
    Yamaguchi Y; Matsuno S; Kagota S; Haginaka J; Kunitomo M
    Eur J Pharmacol; 2002 Feb; 436(1-2):97-105. PubMed ID: 11834252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of endothelium-dependent and Nomega-nitro-L-arginine methyl ester- and indomethacin-resistant arterial relaxation in high-cholesterol-diet fed rabbits by treatment with fluvastatin, an HMG-CoA reductase inhibitor.
    Mitani H; Kimura M
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):55-62. PubMed ID: 12827027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits.
    Hu MY; Li YL; Jiang CH; Liu ZQ; Qu SL; Huang YM
    Nutrition; 2008 Oct; 24(10):1030-8. PubMed ID: 18585898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin, an HMG-CoA reductase inhibitor, protects LDL from oxidative modification in hypercholesterolemic rabbits.
    Yasuhara M; Suzumura K; Tanaka K; Takahashi M; Aoki S; Odawara A; Narita H; Suzuki T
    Biol Pharm Bull; 2000 May; 23(5):570-4. PubMed ID: 10823666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes.
    Yamamoto A; Hoshi K; Ichihara K
    Eur J Pharmacol; 1998 Nov; 361(1):143-9. PubMed ID: 9851551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose ingestion enhances atherosclerosis and deposition of advanced glycated end-products in cholesterol-fed rabbits.
    Tokita Y; Hirayama Y; Sekikawa A; Kotake H; Toyota T; Miyazawa T; Sawai T; Oikawa S
    J Atheroscler Thromb; 2005; 12(5):260-7. PubMed ID: 16205022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy.
    Aviram M; Hussein O; Rosenblat M; Schlezinger S; Hayek T; Keidar S
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):39-45. PubMed ID: 9456275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
    Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits].
    Jorge PA; Almeida EA; Ozaki MR; Jorge M; Carneiro A
    Arq Bras Cardiol; 2005 Apr; 84(4):314-9. PubMed ID: 15880205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.